Edward J. Dulac III - Chief Financial Officer at Fate Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
FATE on Nasdaq
All Insider Reports
All Insider Reports

Edward J. Dulac III - trading volume in the past year for Fate Therapeutics Inc

Holdings reported by Edward J. Dulac III for Fate Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 425K $1.16M $2.73 Feb 1, 2024 Direct Common Stock
Common Stock 101K $788K $7.77 Mar 4, 2024 Direct

Transactions reported by Edward J. Dulac III for Fate Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.